Paris
France
28
2023-11-16
27
2025-10-14
These are the the leading inventors for applications assigned to SANOFI BIOTECHNOLOGY:
SANOFI BIOTECHNOLOGY based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
METHODS FOR TREATING DIGITALLY-IDENTIFIED IL-4/IL-13 RELATED DISORDERS
#2 | 2023-03-30METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST
#3 | 2023-02-23 ✅ Patent 12,502,429 granted on 2025-12-23METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST
#4 | 2022-06-02 ✅ Patent 12,240,898 granted on 2025-03-04Monoclonal anti-IL-1RAcP antibodies
#5 | 2022-03-03 ✅ Patent 11,932,692 granted on 2024-03-19Methods of treating cancer pain by administering a PD-1 inhibitor
#6 | 2021-02-11 ✅ Patent 11,504,426 granted on 2022-11-22Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist
#7 | 2020-10-29 ✅ Patent 11,498,969 granted on 2022-11-15Compositions and methods for treating juvenile idiopathic arthritis
#8 | 2020-08-06 ✅ Patent 11,167,004 granted on 2021-11-09Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
#9 | 2020-07-09 ✅ Patent 11,306,155 granted on 2022-04-19Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody
#10 | 2020-05-07 ✅ Patent 11,639,392 granted on 2023-05-02Anti-IL-1R3 antibodies for use in inflammatory conditions
#11 | 2020-04-02 ✅ Patent 11,319,375 granted on 2022-05-03Methods and compositions for treating subjects having rheumatoid arthritis
#12 | 2020-03-05 ✅ Patent 10,995,150 granted on 2021-05-04Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody
#13 | 2019-12-05 ✅ Patent 11,603,408 granted on 2023-03-14Methods for treating skin infection by administering an IL-4R antagonist
#14 | 2019-11-14 ✅ Patent 11,246,925 granted on 2022-02-15Human antibodies to PCSK9 for use in methods of treating particular groups of subjects
#15 | 2019-02-07 ✅ Patent 11,214,621 granted on 2022-01-04Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
#16 | 2019-02-07 ✅ Patent 11,053,309 granted on 2021-07-06Methods for treating active eosinophilic esophagitis
#17 | 2018-03-22 ✅ Patent 10,485,844 granted on 2019-11-26Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
#18 | 2017-06-15 ✅ Patent 10,968,278 granted on 2021-04-06Compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of using same
#19 | 2016-06-30 ✅ Patent 10,066,017 granted on 2018-09-04Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
#20 | 2016-05-19 ✅ Patent 10,544,232 granted on 2020-01-28Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody
#21 | 2015-09-03 ✅ Patent 10,370,449 granted on 2019-08-06Methods for treating skin infection by administering an IL-4R antagonist
#22 | 2015-06-04 ✅ Patent 10,428,157 granted on 2019-10-01Dosing regimens for use with PCSK9 inhibitors
#23 | 2015-01-15 ✅ Patent 10,059,771 granted on 2018-08-28Methods for treating nasal polyposis by administering an IL-4R antagonist
#24 | 2014-10-09 ✅ Patent 10,927,435 granted on 2021-02-23Compositions for the treatment of rheumatoid arthritis and methods of using same
#25 | 2014-06-26 ✅ Patent 9,682,013 granted on 2017-06-20Pharmaceutical compositions comprising human antibodies to PCSK9
#26 | 2014-06-05 ✅ Patent 9,561,155 granted on 2017-02-07Method of reducing cholesterol levels using a human anti-PCSK9 antibody
#27 | 2014-02-27 ✅ Patent 9,574,004 granted on 2017-02-21Methods for treating or preventing asthma by administering an IL-4R antagonist
#28 | 2013-06-13 ✅ Patent 9,943,594 granted on 2018-04-17Methods for the treatment of rheumatoid arthritis
Also check out Sanofi Biotechnology's (Paris, France) applicant profile with 38 patent applications submitted.
335604 ⎘